Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
2.
Am J Perinatol ; 35(5): 486-493, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29166675

RESUMO

OBJECTIVE: To define the incidence of perianal dermatitis (PD) and determine the usage pattern and cost efficacy of diaper products among neonates admitted to a level IV neonatal intensive care unit (NICU) including those with a diagnosis of neonatal abstinence syndrome (NAS). METHODS: A retrospective cohort study to evaluate neonates with PD based on number of orders for Aquaphor, Bagbalm, Desitin, Flanders, or Nystatin. Various demographic and clinical parameters were recorded. Usage patterns of these five products were analyzed, and their costs estimated. Subgroup analysis was performed among infants with NAS. RESULTS: Of 1,241 admissions, 56.2% had at least one diaper product ordered during their NICU stay, while 52.6% had multiple products ordered. Only 23.0% of all neonates had appropriate documentation of PD. The most common product ordered first was Aquaphor (64.3%), followed by Desitin (19.2%). Note that 86% term NAS infants had PD compared with 28% term non-NAS infants. The estimated product cost was $14,139 over 2 years, averaging $20 per patient. CONCLUSION: Over half of NICU neonates were exposed to one or more diaper products, usually without documented PD diagnosis. Term NAS infants had three times higher incidence of PD than term non-NAS infants. The cost of diaper product use was significant, and possibly underestimated due to lack of documentation.


Assuntos
Dermatite das Fraldas/tratamento farmacológico , Dermatite das Fraldas/epidemiologia , Síndrome de Abstinência Neonatal/complicações , Períneo , Creme para a Pele/economia , Fraldas Infantis , Feminino , Humanos , Incidência , Recém-Nascido , Unidades de Terapia Intensiva Neonatal/estatística & dados numéricos , Masculino , Nistatina/economia , Nistatina/uso terapêutico , Pós/economia , Pós/uso terapêutico , Estudos Retrospectivos , Creme para a Pele/uso terapêutico , Nascimento a Termo , West Virginia/epidemiologia
3.
Pediatr Dermatol ; 30(6): 717-24, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23675632

RESUMO

A petrolatum and zinc oxide-based ointment containing 0.25% miconazole nitrate is reported to be effective and well tolerated in the treatment of diaper dermatitis complicated by cutaneous candidiasis (DDCC). This prospective, multicenter, open-label, long-term, phase IV study investigated the potential resistance of Candida spp. to repeated topical use of 0.25% miconazole nitrate in infants age 15 months and younger with moderate to severe DDCC. For initial and recurring episodes of DDCC over the 2-year study period, subjects were treated with a 7-day course of 0.25% miconazole nitrate ointment (active components: miconazole nitrate 0.25%, zinc oxide 15%, and white petrolatum 81.35%) with a 7-day follow-up. Clinical and mycologic evaluations were conducted before treatment (day 0) and 7 days after treatment (day 14). Potential resistance to miconazole was defined using an arbitrary breakpoint of minimum inhibitory concentration of 2 µg/mL. There was no evidence of resistance to miconazole in Candida spp. after single or repeated treatment courses of 0.25% miconazole nitrate ointment. For the initial episode of DDCC, 83 of 168 subjects (49.4%) achieved a clinical cure, 77 (45.8%) achieved a mycologic cure, and 49 (29.2%) achieved an overall cure (clinical and mycologic). The overall cure rate for recurrent episodes of DDCC was similar to or numerically greater than rates observed for the initial episode. Treatment of DDCC with 0.25% miconazole nitrate ointment was effective and generally well tolerated. No evidence of the development of resistance to miconazole in Candida spp. was observed.


Assuntos
Antifúngicos/administração & dosagem , Candidíase/tratamento farmacológico , Dermatite das Fraldas/tratamento farmacológico , Farmacorresistência Fúngica , Miconazol/administração & dosagem , Antifúngicos/efeitos adversos , Dermatite/tratamento farmacológico , Fármacos Dermatológicos/administração & dosagem , Fármacos Dermatológicos/efeitos adversos , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Miconazol/efeitos adversos , Testes de Sensibilidade Microbiana , Pomadas/administração & dosagem , Pomadas/efeitos adversos , Vaselina/administração & dosagem , Vaselina/efeitos adversos , Estudos Prospectivos , Índice de Gravidade de Doença , Resultado do Tratamento , Óxido de Zinco/administração & dosagem , Óxido de Zinco/efeitos adversos
4.
Int J Cosmet Sci ; 31(5): 369-74, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19467034

RESUMO

Diaper dermatitis affects nearly 50% of infants as well as some bed-ridden adults particularly in the elderly people. This condition is induced by irritation and maceration, and may be further exacerbated by Candida sp. colonization and infection. A key factor in the pathogenesis is the alteration in both the barrier function and the water-holding capacity of the stratum corneum. The purpose of this study was to assess the effects of an unmedicated zinc oxide-petrolatum paste and to observe for possible shielding and restoring effects on the water-holding capacity of the stratum corneum altered by diaper dermatitis. The paste appeared to load the hollow skin microrelief. It was inferred that this effect was responsible for a reticulated shielding effect. Compared with healthy skin and untreated diaper dermatitis, the application of the anhydrous paste resulted in a trend to normalize electrometric properties of skin reflecting the combination of transepidermal water loss and the water-holding capacity of the stratum corneum.


Assuntos
Dermatite das Fraldas/tratamento farmacológico , Óxido de Zinco/administração & dosagem , Administração Tópica , Adulto , Impedância Elétrica , Feminino , Humanos , Lactente , Masculino , Vaselina/administração & dosagem , Fenômenos Fisiológicos da Pele/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA